| Summary of Accrued Expenses |
The following table summarizes the Company’s accrued expenses for each of the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
As of
June 30, 2025 |
|
|
As of
December 31, 2024 |
|
|
|
(in thousands) |
|
Product revenue related reserves |
|
$ |
145,275 |
|
|
$ |
109,157 |
|
Accrued contract manufacturing costs |
|
|
59,513 |
|
|
|
77,842 |
|
Accrued employee compensation costs |
|
|
55,232 |
|
|
|
91,119 |
|
Accrued income taxes |
|
|
18,730 |
|
|
|
17,391 |
|
Accrued professional fees |
|
|
26,611 |
|
|
|
17,691 |
|
Accrued clinical and pre-clinical costs |
|
|
26,152 |
|
|
|
26,849 |
|
Accrued royalties |
|
|
13,996 |
|
|
|
16,625 |
|
Accrued fixed assets |
|
|
8,150 |
|
|
|
5,305 |
|
Accrued milestone and license expense |
|
|
6,080 |
|
|
|
2,000 |
|
Accrued clinical collaboration costs |
|
|
7,003 |
|
|
|
— |
|
Accrued interest expense |
|
|
4,727 |
|
|
|
4,192 |
|
Other |
|
|
5,930 |
|
|
|
5,342 |
|
Total accrued expenses |
|
$ |
377,399 |
|
|
$ |
373,513 |
|
|